Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörg Thomas Hartmann

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 5, 2018
[Medical Treatment of Soft Tissue Sarcoma]Jörg Thomas Hartmann
Current Oncology Reports|June 11, 2005
New drug developments for patients with metastatic soft tissue sarcomaJörg Thomas Hartmann, Shreyaskumar Patel
Drugs|January 6, 2005
Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcomaJörg Thomas Hartmann, Shreyaskumar Patel
Expert Opinion on Pharmacotherapy|June 5, 2003
Toxicity of platinum compoundsJörg Thomas Hartmann, Hans-Peter Lipp
American Journal of Clinical Dermatology|June 25, 2008
Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcomaHans-Georg Kopp, Shreyaskumar Patel, Björn Brücher, et al.
Current Drug Metabolism|August 20, 2009
Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effectsJörg Thomas Hartmann, Michael Haap, Hans-Georg Kopp, et al.
Onkologie|May 24, 2008
Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectivesRalf-Dieter Hofheinz, Ulrich Beyer, Salah-Eddin Al-Batran, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2008
Is increased body mass index associated with the incidence of testicular germ cell cancer?Klaus-Peter Dieckmann, Jörg Thomas Hartmann, Johannes Classen, et al.
The Journal of Urology|May 21, 2010
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumorsAnja Lorch, Oliver Rick, Thomas Wündisch, et al.
Anticancer Research|August 19, 2007
A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancerChristof Burkart, Carsten Bokemeyer, Bodo Klump, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|October 5, 2018
[Medical Treatment of Soft Tissue Sarcoma]Jörg Thomas Hartmann
Current Oncology Reports|June 11, 2005
New drug developments for patients with metastatic soft tissue sarcomaJörg Thomas Hartmann, Shreyaskumar Patel
Drugs|January 6, 2005
Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcomaJörg Thomas Hartmann, Shreyaskumar Patel
Expert Opinion on Pharmacotherapy|June 5, 2003
Toxicity of platinum compoundsJörg Thomas Hartmann, Hans-Peter Lipp
American Journal of Clinical Dermatology|June 25, 2008
Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcomaHans-Georg Kopp, Shreyaskumar Patel, Björn Brücher, et al.
Current Drug Metabolism|August 20, 2009
Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effectsJörg Thomas Hartmann, Michael Haap, Hans-Georg Kopp, et al.
Onkologie|May 24, 2008
Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectivesRalf-Dieter Hofheinz, Ulrich Beyer, Salah-Eddin Al-Batran, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2008
Is increased body mass index associated with the incidence of testicular germ cell cancer?Klaus-Peter Dieckmann, Jörg Thomas Hartmann, Johannes Classen, et al.
The Journal of Urology|May 21, 2010
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumorsAnja Lorch, Oliver Rick, Thomas Wündisch, et al.
Anticancer Research|August 19, 2007
A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancerChristof Burkart, Carsten Bokemeyer, Bodo Klump, et al.
Pageof 3